Kauris-CT 500 Injection
Marketer
Kauris Care Private Limited
Salt Composition
Ceftriaxone (500mg)
Overview Kauris-CT 500 Injection
Cephalosporin antibiotic Ceftibuten (Kauris-CT 500 Injection) combats various bacterial infections. Its applications span diverse sites including the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactic use during surgery is also indicated. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined individually. Regular, evenly spaced injections, as directed, are crucial; premature cessation risks relapse. Common side effects—diarrhea, rash, altered liver function tests, and atypical blood counts (e.g., eosinophilia, leukopenia, thrombocytopenia)—are generally mild but warrant reporting. Injection site erythema or pain may occur. Prior to treatment, disclose any antibiotic allergies, liver or kidney issues, and all concurrent medications to your doctor, as interactions are possible.
Primary Ingredients of Kauris-CT 500 Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Kauris-CT 500 Injection
Managing bacterial illnesses
Major Benefits of Kauris-CT 500 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Kauris-CT 500 Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Kauris-CT 500 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Kauris-CT 500 Injection works:
Kauris-CT 500 Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent use of Kauris-CT 500 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Administering Kauris-CT 500 Injection during pregnancy is considered safe. The preponderance of research indicates minimal or nonexistent hazard to the fetus.
Breast feedingCAUTION
The administration of Kauris-CT 500 Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be discontinued until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Kauris-CT 500 Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneySAFE IF PRESCRIBED
Kauris-CT 500 Injection poses no known safety risk for individuals with renal impairment, and no dosage alteration is necessary. Nevertheless, disclosure of any pre-existing kidney conditions to your physician is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Kauris-CT 500 Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate Kauris-CT 500 Injection dose alteration; however, physician consultation is advised for all patients.
What if you forget to take Kauris-CT 500 Injection :
Omit a Kauris-CT 500 Injection dose? Seek medical advice immediately.
Facts to Know About Kauris-CT 500 Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently